Search for: "John Jenkins" Results 1181 - 1200 of 1,818
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2016, 3:00 am by John Jenkins
Please take a moment to participate in this anonymous poll: survey services – John Jenkins [read post]
13 Sep 2011, 4:07 am by Broc Romanek
Webcast: "Current Developments in Capital Raising" Tune in tomorrow for the webcast - "Current Developments in Capital Raising" - to hear John Jenkins of Calfee Halter, Michael Kaplan of Davis Polk, Louis Lehot of Sheppard Mullin, and Dave Lynn of TheCorporateCounsel.net and Morrison & Foerster explore the latest developments in the capital markets, including alternatives such as PIPEs, registered direct offerings, "at-the-market" offerings,… [read post]
31 Aug 2016, 3:00 am by John Jenkins
– Audit Report Transparency: Netherlands Trumps US – Hands Down – Omnicare Applied to Audit Reports – John Jenkins [read post]
12 Jul 2017, 3:43 am by Broc Romanek
Tomorrow’s Webcast: “12 Strange Things in the Securities Laws” Tune in tomorrow for the webcast – “12 Strange Things in the Securities Laws” – to hear Fenwick & West’s Dawn Belt, TheCorporateCounsel.net’s John Jenkins, Manatt Phelps’ Ben Orlanski and Faegre Baker Daniels’ Amy Seidel tackle the practical solutions to bizarre & illogical things that happen in your daily practice. [read post]
14 Dec 2016, 3:00 am by John Jenkins
Here are some of the latest entries: – Issuing Shares Via Blockchain: Delaware Poised to Act – Describing an Officer’s Duties 101 – Data Privacy: More Federal Agencies Join Enforcement Bandwagon – Stats: Controlled Companies – How Law Firms Should Strengthen Their Cybersecurity – John Jenkins [read post]
27 Feb 2009, 9:48 am
John Jenkins, the Director of the FDA Office of New Drugs stated, "I think he [Dr. [read post]
29 Nov 2010, 6:48 pm by M. Brandon Smith
“The drug’s effectiveness in reducing pain is no longer enough to outweigh the drug’s serious potential heart risks,” said John Jenkins, M.D., director of the Office of New Drugs in the FDA’s Center for Drug Evaluation and Research. [read post]